◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › I › IMCR

Immunocore Holdings plc - American Depositary Shares (IMCR) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

NASDAQ · DATA UPDATED 2026-09-13

Immunocore Holdings plc - American Depositary Shares (IMCR) operates in the NASDAQ industry and is headquartered in Abingdon, United Kingdom with about 524 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, IMCR reported $298M in revenue and ($26M) in net income.

Immunocore Holdings plc, together with its subsidiaries, engages in the development and commercialization of immunomodulating medicines for patients with cancer, infectious diseases, and autoimmune disease in the United States, Europe, and internationally.

Interactive charts & full statements → Open the IMCR valuation workbench →

IMCR Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31
Total Revenue	$404M	$298M	$248M	$197M	$144M	$27M	$30M	$26M	$24M	$14M	$16M	$11M	$6M	$2M
Gross Profit	$399M	$291M	$242M	$197M	$139M	$27M	($45M)	($74M)	$24M	$14M	$16M	$11M	$6M	$2M
Gross Margin %	98.9%	97.9%	97.8%	99.6%	96.3%	100.0%	-148.4%	-289.5%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%
Operating Income (EBIT)	($17M)	($34M)	($56M)	($47M)	($43M)	($129M)	($86M)	($118M)	($93M)	($68M)	($32M)	($14M)	($7M)	($5M)
Operating Margin %	-4.3%	-11.3%	-22.7%	-23.9%	-29.7%	-478.5%	-286.2%	-460.9%	-395.1%	-467.4%	-197.3%	-119.2%	-114.6%	-234.3%
Net Income	($9M)	($26M)	($41M)	($44M)	($43M)	($133M)	($74M)	($104M)	($72M)	($50M)	($23M)	$13M	($6M)	($4M)
Net Margin %	-2.3%	-8.9%	-16.4%	-22.2%	-30.1%	-493.4%	-246.0%	-404.9%	-302.8%	-343.1%	-140.5%	117.4%	-87.7%	-180.6%
EBITDA	$16M	$0M	($39M)	($41M)	($38M)	($124M)	($82M)	($112M)	($87M)	($64M)	($30M)	($11M)	($7M)	($4M)
Earnings Per Share (EPS)	$-0.20	$-0.52	$-0.82	$-0.89	$-0.95	$-3.04	$-2.33	$-3.81	$-2.62	$-20.16	$-9.44	—	$-2.53	—
Shares Outstanding (M)	51M	50M	50M	49M	46M	44M	32M	27M	27M	2M	2M	—	2M	—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

IMCR Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$116M	$107M	$77M	$104M	$98M	$94M	$84M	$80M
Gross Profit	$115M	$106M	$75M	$103M	$97M	$93M	$84M	$80M
Gross Margin %	99.1%	99.6%	96.6%	99.5%	98.9%	99.1%	99.6%	99.4%
Operating Income (EBIT)	($3M)	$7M	($15M)	($7M)	($15M)	($4M)	($19M)	($9M)
Operating Margin %	-2.6%	6.8%	-18.9%	-6.9%	-15.2%	-3.9%	-23.1%	-10.6%
Net Income	($1M)	$13M	($22M)	$1M	($10M)	$5M	($24M)	$9M
Net Margin %	-0.7%	12.2%	-28.8%	0.8%	-10.5%	5.3%	-28.3%	10.9%
EBITDA	$4M	$17M	($8M)	$4M	($6M)	$10M	($15M)	$11M
Earnings Per Share (EPS)	$-0.02	$0.25	$-0.44	$0.02	$-0.20	$0.10	$-0.48	$0.17
Shares Outstanding (M)	51M	53M	50M	50M	50M	52M	50M	53M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

IMCR Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31
Cash from Operations (CFO)	($56M)	($8M)	$26M	$2M	($49M)	($143M)	($61M)	($101M)	($17M)	($62M)	($37M)	($18M)	$40M	$11M
Capital Expenditures (CapEx)	$6M	$3M	$5M	$4M	$2M	$1M	$3M	$4M	$4M	$18M	$6M	$6M	$2M	$1M
Free Cash Flow (FCF)	($63M)	($11M)	$21M	($2M)	($51M)	($144M)	($64M)	($106M)	($20M)	($79M)	($43M)	($24M)	$38M	$11M
FCF Margin %	-15.5%	-3.8%	8.4%	-1.0%	-35.6%	-534.3%	-211.4%	-411.6%	-85.2%	-550.0%	-261.7%	-207.0%	592.0%	522.5%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

IMCR Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	($5M)	($14M)	($33M)	($4M)	$26M	$0M	($14M)	$21M
Capital Expenditures (CapEx)	$1M	$2M	$3M	$1M	$0M	$0M	$4M	$1M
Free Cash Flow (FCF)	($6M)	($16M)	($36M)	($5M)	$26M	$0M	($18M)	$20M
FCF Margin %	-5.4%	-14.6%	-45.9%	-5.0%	26.1%	0.1%	-20.9%	25.3%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

IMCR Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31
Total Assets	$1.1B	$1.1B	$1.0B	$597M	$527M	$407M	$197M	$246M	$196M	$198M	$219M	$274M	$61M	$20M
Cash & Cash Equivalents	$485M	$468M	$456M	$443M	$402M	$321M	$177M	$98M	$124M	$84M	$134M	$220M	$51M	$16M
Total Liabilities	$700M	$686M	$649M	$228M	$188M	$176M	$142M	$226M	$139M	$60M	$44M	$59M	$63M	$8M
Total Debt (Short + Long-Term)	$396M	$395M	$393M	$49M	$41M	$39M	$49M	$28M	$19M	$0M	$0M	$0M	$0M	$0M
Total Shareholders' Equity	$420M	$381M	$361M	$369M	$339M	$232M	$55M	$20M	$57M	$138M	$175M	$214M	($2M)	$3M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive IMCR viewer.

Other Companies in Software & IT Services

MRC · Mercantile Ord — £2 billion
HE · Hawaiian Electric Industries, Inc. — $2 billion
PNL · Personal Assets Ord — £2 billion
EVTC · Evertec, Inc. — $2 billion
UNC · United Corporations Ord — C$2 billion
BL · BlackLine, Inc. - — $2 billion
LWDB · Law Debenture Corporation Ord — £2 billion
JMGI · JPMorgan Emerging Markets Growth & Income plc. — £2 billion

← IMCO All “I” companies IMCV →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.